Asr Vermogensbeheer N.V. Incyte Corp Transaction History
Asr Vermogensbeheer N.V.
- $7.71 Trillion
- Q2 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Incyte Corp stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 5,734 shares of INCY stock, worth $500,635. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,734
Previous 5,764
0.52%
Holding current value
$500,635
Previous $349 Million
11.9%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding INCY
# of Institutions
741Shares Held
203MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.68 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.86 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.76 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.27 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$862 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19.4B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...